Effect of catalase activators and inhibitors on ethanol pharmacokinetic parameteres and ethanol and aldehyde-metabolizing enzyme activities in the rat liver and brain

Biomeditsinskaya Khimiya

Volumn 56, Issue 4, 2010, Pages 499-505

  Bardina, L R ^a   Pronko, P S ^a   Satanovskaya, V I ^a   Aliyeva, Ye V ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Belarus)

Author keywords

Alcohol dehydrogenase; Aldehyde dehydrogenase; Catalase; Ethanol; Microsomal cthanol oxidizing system; Pharmacokinetics

Indexed keywords

RATTUS;

ACETALDEHYDE; ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; CATALASE; CYTOCHROME P450; ENZYME ACTIVATOR; ENZYME INHIBITOR; MICROSOMAL ETHANOL OXIDIZING SYSTEM; MICROSOMAL ETHANOL-OXIDIZING SYSTEM;

ANIMAL; ARTICLE; BRAIN; DRUG ANTAGONISM; LIVER; MALE; METABOLISM; RAT; WISTAR RAT;

ACETALDEHYDE; ALCOHOL DEHYDROGENASE; ALCOHOL OXIDOREDUCTASES; ALDEHYDE DEHYDROGENASE; ANIMALS; BRAIN; CATALASE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATORS; ENZYME INHIBITORS; ETHANOL; LIVER; MALE; RATS; RATS, WISTAR;

EID: 78149308444     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: 10.18097/pbmc20105604499     Document Type: Article

References (21)

1. Lieber C.S. (1983) Biochem. Soc. Trans., 16(3), 241-247.
2. Pastor R., Sanchis-Segura C., Aragon C.M.G. (2002) Psychopharmacol., 165, 51-59.
3. Litterst C.Z., Mimnaugh E.G., Reagan R.Z., Gram T.E. (1975) Life Science, 17(5), 813-818.
4. Handler JA., Bradford B. U., Glassman E. et al. (1986) Biochem. Pharmacol, 35(24), 4487-4492.
5. Aebi II. (1984) Methods Enzymol., 105, 121-126.
6. Nakajama M., Kato J, Kohgo Y, Katsuki S, Takeichi N (1993) Alcohol Alcohol., 28(SlB), 105-108.
7. Lieber C.S., De Carli Z.M. (1970) J. Biol. Chem., 245, 2502-2512.
8. Tottmar S.O.C., Petterson IL, Kiessling KU. (1973) Biochem. J., 135, 577-586.
9. Erwin V.G., Deitrich R.A. (1966) J. Biol. Chem., 241, 3533-3539.
10. Lowry O.H., Rosebrough N.J., FarrA.L., Randal R.J. (1951) J. Biol. Chem., 193, 265-275.
11. Correa M., Miquel M., Sanchis-Segura C., Aragon C.M.G. (1999) Alcohol. Clin. Exp. Res., 23, 799-805.
12. Smith B.R., Aragon C.M.G., Amit Z. (1997) Addict. Biol., 2, 277-289.
13. Escarabajal M.D., Miquel M., Aragon C.M.G (2000) J. Stud. Alcohol., 61,463-498.
14. Theofanopoulos V., Lau-Cam C.A. (1998) Adv. Exper. Med. Biol., 442, 309-318.
15. Ward R.J, Kest W, Bruyees R. Lallemand F., De Witter P. (2001) Alcohol Alcohol., 36(1), 39-43.
16. Watanabe A., IIobora N., Nagashima IL (1985) Experien., 41, 1421-1422.
17. Aragon C.M.G, Pesold C.N., Amit Z. (1992) Alcohol., 9, 207-211.
18. Tipton K.F., Houslay M.D., Turner A.J. (1977) Neurochem. Neuropharmacol., 1. 103-138.
19. Elliot B.M., Elcombe C.R. (1987) Carcinogenesis, 8, (9) 1213-1218.
20. Correa M., Pascual H., Sanchis-Segura C., Guerri C., Aragon C.M. (2005) Pharmacol. Biochem. Behav., 82(3), 443-452.
21. Aragon C.M.G., Stotl and L.M.,Amit Z (1991)Alcohol. Clin. Exp. Res., 15,165-169.